Core Laboratories (CLB) Change in Accured Expenses (2022 - 2026)

Core Laboratories' Change in Accured Expenses history runs 5 years deep, the most recent figure standing at -$6.5 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 3985.03% year-over-year to -$6.5 million; the TTM figure through Jun 2026 stood at -$12.6 million (down 412.99% YoY), while the FY2025 annual figure was -$5.1 million, down 299.92% from the prior year.
• Change in Accured Expenses for Q2 2026 stood at -$6.5 million, down from -$1.9 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $6.6 million in Q2 2024, with the low at -$6.5 million in Q2 2026.
• The 5-year median for Change in Accured Expenses is -$1.5 million (2023), against an average of -$933062.5.
• The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses soared 261.36% in 2024, then plunged 3985.03% in 2026.
• Core Laboratories' Change in Accured Expenses stood at $1.5 million in 2022, then soared by 64.98% to $2.5 million in 2023, then plunged by 94.55% to $139000.0 in 2024, then plunged by 1315.83% to -$1.7 million in 2025, then plunged by 283.91% to -$6.5 million in 2026.
• Business Quant data shows CLB's Change in Accured Expenses at -$6.5 million in Q2 2026, -$1.9 million in Q1 2026, and -$1.7 million in Q4 2025.